PCOS and Prediabetes: The Screening Interval Most People Miss

How Often Should You Actually Be Screened for Prediabetes With PCOS?

Guideline recommendations call for type 2 diabetes screening every 1 to 3 years in all women with PCOS, across every BMI category and age range, with the exact frequency adjusted for additional risk factors — that specific interval comes directly from a 2019 analysis of the Australian Longitudinal Study on Women’s Health, which tracked 1,919 person-years of data behind the recommendation. That is a wider window than “once you’re diagnosed and then never again,” which is how many people describe their actual experience of PCOS care once the initial workup is done. It is also narrower than “only if you gain weight” — the same analysis found PCOS added diabetes risk across healthy-weight, overweight and obese categories alike, just at different absolute rates.

The gap usually isn’t refusal — it’s fragmentation. A glucose test run once during the diagnostic workup gets treated, understandably, as something already handled. Reproductive endocrinology, primary care and any specialist managing hair, skin or cycle symptoms don’t always share a single tracker for when the next metabolic check is due, so the interval quietly lapses without anyone deciding it should. Naming the number — 1 to 3 years, adjusted for your own risk factors — turns that into something you can ask about on a specific date rather than a vague intention to “get bloodwork done at some point.” This page sits inside the weight-loss section, which covers metabolic markers generally — insulin, glucose, lipids, blood pressure — rather than a number on a scale.

OGTT vs HbA1c vs Fasting Glucose: Which Test Should You Actually Ask For?

The oral glucose tolerance test outperformed both alternatives against the same reference standard in a 2024 systematic review of nine studies and 2,628 women with PCOS — the review that directly informed the 2023 International PCOS Guideline’s recommendation that OGTT is the optimal method for diagnosing type 2 diabetes in this population. Using the standard HbA1c cutoff of 6.5% for diabetes, sensitivity against OGTT was only 50.0% — meaning roughly half of the women who had diabetes by OGTT criteria would have been missed by HbA1c alone. Fasting plasma glucose did better but still fell short, at 58.1% sensitivity.

For prediabetes specifically — the earlier, more actionable stage — the gap is worse. A cross-sectional study of 671 women with PCOS found HbA1c-defined prediabetes agreed with full ADA-criteria prediabetes at a kappa of only 0.36, and fasting-glucose-defined prediabetes agreed at a kappa of just 0.05 — statistically close to no agreement at all. The study’s own conclusion: “findings do not support the recommendation that FG or HbA1c can be used for the screening of prediabetes in women with PCOS.” If your clinic only offers a fasting glucose or an HbA1c and calls it a diabetes screen, ask specifically whether an OGTT is available — the difference is not academic.

What Actually Happens During an OGTT, and What Do the Numbers Mean?

A 2-hour oral glucose tolerance test involves one fasting blood draw, then drinking a 75 g glucose solution, then a second blood draw exactly 2 hours later — some clinics add a 1-hour draw as well, though the 2023 guideline’s evidence is built on the 2-hour value. The three results below, built from the American Diabetes Association criteria used in the Austrian cohort study above, are the same three thresholds a normal, prediabetic or diabetic result gets sorted into, whichever test combination your clinic actually runs.

The reason the guideline leans on the 2-hour column specifically, rather than the fasting column, is mechanical. Insulin resistance in PCOS works by pushing the pancreas to produce more insulin to hold fasting glucose in a normal range — that compensation is exactly why a fasting number alone can look clean while the same person’s glucose handling is already abnormal once it’s challenged with an actual glucose load. The 2-hour value is where that compensation runs out and shows up as a number, which is also why fasting glucose’s 58.1% sensitivity in the diagnostic-accuracy review above still leaves close to two in five diabetes cases undetected.

How High Is the Real Risk of Progressing to Diabetes With PCOS?

Three named cohorts, tracked for very different lengths of time, all point the same direction.

Read the Australian data carefully: PCOS added more relative risk to healthy-weight women than to obese women, even though obese women with PCOS still had the highest absolute incidence rate. That is why “you’re not overweight, so you don’t need to worry about diabetes” is not a conclusion this data supports — it’s close to the opposite. Insulin resistance itself runs about 27% lower regardless of body weight, and it is the mechanism underneath these numbers, not a side effect of size.

What Does the Guideline Actually Say About Diet for Prediabetes Risk?

The 2023 international guideline treats lifestyle change as first-line for metabolic risk in PCOS generally, without prescribing one named diet as the prediabetes diet — no single eating pattern has trial evidence specific to preventing progression from prediabetes to diabetes in PCOS. What does have trial evidence is diet’s effect on the insulin resistance that drives glucose intolerance in the first place: Treating insulin resistance in PCOS ranks the interventions with measured effect sizes, including which dietary pattern moved HOMA-IR and by how much. Nothing here is about a target weight or a restrictive plan — it’s about the same glucose and insulin numbers this page is telling you to get rechecked on schedule.

It’s also worth saying what the guideline does not claim. It does not say diet alone prevents progression to diabetes in PCOS, and it does not rank one diet above others as protective against prediabetes specifically. What it does say is that metabolic risk factors — including glucose tolerance — belong inside routine PCOS care rather than being treated as a separate concern only relevant to people managing their weight. That framing matters more than any specific meal plan: metabolic monitoring is something you’re owed as part of standard PCOS management, not something you have to justify by pointing at the scale first.

Who Should Be Rescreened Sooner Than Every 1 to 3 Years?

A family history of type 2 diabetes, a personal history of gestational diabetes, obesity, or existing signs of insulin resistance all push someone toward the shorter end of the 1-to-3-year window rather than the longer one, per the same guideline evidence base. The Turkish follow-up study above also found that once impaired glucose tolerance was already present, roughly a third of women progressed to type 2 diabetes within about two and a half years — a much faster clock than the general screening interval assumes, which is why the guideline treats an existing IGT result as grounds for closer monitoring than someone with normal tolerance at their last test. What gets tested at a PCOS diagnosis, and in what order, is covered separately if you’re earlier in the process than a rescreening conversation.

A prior pregnancy complicated by gestational diabetes deserves its own mention, since it’s easy to treat as a closed chapter once the pregnancy ends. It isn’t, in this population specifically — it’s one of the named risk factors the guideline uses to justify screening sooner than the standard interval, on top of whatever risk PCOS itself already carries. None of this is a reason to assume the worst outcome is coming. It’s a reason to say, out loud, at your next visit, which of these factors apply to you, so the interval you actually get matches the risk you actually carry instead of a generic default.

You may see this condition written as polyendocrine metabolic ovarian syndrome (PMOS), after a 2026 global consensus of more than 50 medical organisations renamed it. The screening interval, the test comparison and the progression data above are unchanged by the name — this page uses PCOS because that’s still what most people search.

What to Bring to Your Next Appointment

Ask three things: when your glucose tolerance was last actually checked, whether that check was an OGTT or something less sensitive, and — given your personal risk factors — whether you’re due now or can wait toward the three-year end of the interval. The lipid pattern that often travels alongside insulin resistance in PCOS is worth asking about in the same appointment, since both are usually drawn from the same blood sample.